Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Depressed patients will receive 6 weeks of citaloprma (20-40mg) therapy. Subjects who have an
inadequate response (partial or non-responder) will be randomized to receive either
mecamylamine (5-10mg) or placebo added to their citalopram for a further 8 weeks.